Lucy Gee
Dr Ben Barron-Millar
Dr Marco Zaki
Dr Saimir Luli
Rachel Burgoyne
et al. | Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice | 2023 |
|
Dr Jack Leslie
Dr Hannah Paish
Amy Collins
Rebecca Scott
Abi Watson
et al. | A Mammalian Target of Rapamycin-Perilipin 3 (mTORC1-Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis | 2021 |
|
Dr Massimo Younes
Rachel Burgoyne
Dr Dina Tiniakos
Dr Olivier Govaere
| Clinical implications of hepatic progenitor cell activation in non-alcoholic fatty liver disease | 2021 |
|
Dr Lee Borthwick
Ben Barksby
Rachel Burgoyne
Rory Barnes
Professor Andrew Fisher
et al. | Pharmacological characterisation of GSK3335103, an oral αvβ6 integrin small molecule RGD-mimetic inhibitor for the treatment of fibrotic disease | 2021 |
|
Rachel Burgoyne
Professor Andrew Fisher
Dr Lee Borthwick
| The role of epithelial damage in the pulmonary immune response | 2021 |
|
Dr Jack Leslie
Dr Marina Garcia Macia
Dr Saimir Luli
Dr Julie Worrell
William Reilly
et al. | c-Rel orchestrates energy-dependant epithelial and macrophage reprogramming in fibrosis | 2020 |
|
Dr Jack Leslie
Benjamin Millar
Alicia Del Carpio Pons
Rachel Burgoyne
Joseph Frost
et al. | FPR-1 is an important regulator of neutrophil recruitment and a tissue-specific driver of pulmonary fibrosis | 2020 |
|
Dr Lee Borthwick
Ben Barksby
Rachel Burgoyne
Rory Barnes
Professor Andrew Fisher
et al. | Translational pharmacology of an inhaled small molecule αvβ6 integrin inhibitor for idiopathic pulmonary fibrosis | 2020 |
|
